IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients

BackgroundIn the U.S., African Americans (AAs) present with the highest incidence and mortality rates for Colorectal Cancer (CRC). When compared to Caucasian American (CA) patients, AAs also have reduced response to the first line standard of care chemotherapeutic agent 5-Fluorouracil (5-FU). Previo...

Cijeli opis

Bibliografski detalji
Glavni autori: Marzia Spagnardi, Jenny Paredes, Jovanny Zabaleta, Jone Garai, Tiana Reyes, Laura A. Martello, Jennie L. Williams
Format: Članak
Jezik:English
Izdano: Frontiers Media S.A. 2022-12-01
Serija:Frontiers in Oncology
Teme:
Online pristup:https://www.frontiersin.org/articles/10.3389/fonc.2022.1010380/full